Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shattuck LabsSTTK +4.80%42 Current Ratio is 22.06 as of Mar. 2026, which is 113% above its 10-year median of 10.38. GuruFocus rates STTK with a GF Score™ of 42/100 and a GF Value™ of $1.05 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,411 Biotechnology companies, Shattuck Labs ranks better than 93.69% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Shattuck Labs's current ratio for the quarter that ended in Mar. 2026 was 22.06.
Shattuck Labs has a current ratio of 22.06. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Shattuck Labs's Current Ratio or its related term are showing as below:
STTK'
s Current Ratio Range Over the Past 10 Years
Min: 2.12 Med: 10.38 Max: 22.06
Current: 22.06
During the past 8 years, Shattuck Labs's highest Current Ratio was 22.06. The lowest was 2.12. And the median was 10.38.
STTK's Current Ratio is ranked better than 93.69% of 1411
companies
in the Biotechnology industry
Industry Median: 3.88
vs STTK: 22.06
Shattuck Labs (NAS:STTK) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Shattuck Labs Current Ratio Related Terms
Shattuck Labs Current Ratio Historical Data
* Premium members only.
The historical data trend for Shattuck Labs's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STTK vs ACHV, CRMD, EIKN: Current Ratio Comparison
For the Biotechnology subindustry, Shattuck Labs's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shattuck Labs Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shattuck Labs's Current Ratio distribution charts can be found below:
* The bar in red indicates where Shattuck Labs's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shattuck Labs (STTK) has a Current Ratio of 22.06 as of Mar. 2026. This is 113% above median its historical median of 10.38. Over the past decade, Shattuck Labs' Current Ratio has ranged from 2.12 to 22.06. According to the industry distribution chart, Shattuck Labs ranks #89 out of 1411 companies in the Biotechnology industry, placing it in the top 6.3%.
Is Shattuck Labs' Current Ratio too high?
Shattuck Labs' current Current Ratio of 22.06 is 113% above median its 10-year median of 10.38. Over the past 10 years, this metric has ranged from a low of 2.12 to a high of 22.06. The Biotechnology industry median Current Ratio is 3.88. Shattuck Labs' value of 22.06 is 468.6% above this industry median. Based on the distribution chart, Shattuck Labs ranks #89 out of 1411 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shattuck Labs has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shattuck Labs' Current Ratio compare to ACHV and CRMD?
According to the Biotechnology industry distribution chart, Shattuck Labs ranks #89 out of 1411 companies for Current Ratio. This places Shattuck Labs in the top 6% of its industry — outperforming the majority of peers. The industry median Current Ratio is 3.88. Shattuck Labs' value of 22.06 is 468.6% above this benchmark. Historically, Shattuck Labs' own Current Ratio has ranged from 2.12 to 22.06 over the past decade. While the company's 10-year median is 10.38 vs. the industry median of 3.88, Shattuck Labs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.88, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shattuck Labs's current Current Ratio of 22.06 is 468.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shattuck Labs's current Current Ratio is 22.06, which is 113% above median its own 10-year median of 10.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shattuck Labs stock overvalued right now?
Based on GuruFocus' analysis, Shattuck Labs (STTK) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.05, compared to a current price of $7.42 — trading 606.7% above its estimated fair value. The current Current Ratio is 22.06, which is 113% above median its 10-year median of 10.38 and 468.6% above the Biotechnology industry median of 3.88. Shattuck Labs' overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Shattuck Labs (STTK), the current Current Ratio is 22.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shattuck Labs (STTK) Overvalued in 2026?
Based on GuruFocus' analysis, Shattuck Labs stock appears to be overvalued.
The current stock price of $7.42 is trading 606.7% above its estimated GF Value™ of $1.05.
GuruFocus considers Shattuck Labs to be Significantly Overvalued.
Key valuation signals for STTK:
Current Ratio: 22.06 (113% above median its 10-year median of 10.38)
GF Value™: $1.05 vs. price of $7.42 (606.7% above fair value)
Industry Position: 468.6% above the Biotechnology median (#89 of 1411)
No single metric tells the full story. See the STTK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
42GF Score
Get the complete analysis for STTK
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STTK has been successfully added to your 
